Cargando…
TLR9 deficiency alleviates doxorubicin‐induced cardiotoxicity via the regulation of autophagy
Doxorubicin is a commonly used anthracycline chemotherapeutic drug. Its application for treatment has been impeded by its cardiotoxicity as it is detrimental and fatal. DNA damage, cardiac inflammation, oxidative stress and cell death are the critical links in DOX‐induced myocardial injury. Previous...
Autores principales: | Guo, Zhen, Tang, Nan, Liu, Fang‐Yuan, Yang, Zheng, Ma, Shu‐Qing, An, Peng, Wu, Hai‐Ming, Fan, Di, Tang, Qi‐Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521247/ https://www.ncbi.nlm.nih.gov/pubmed/33140921 http://dx.doi.org/10.1111/jcmm.15719 |
Ejemplares similares
-
Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
por: Zhang, Xin, et al.
Publicado: (2019) -
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice
por: Ma, Zhen-Guo, et al.
Publicado: (2020) -
FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
por: Zhang, Xin, et al.
Publicado: (2019) -
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice
por: Yan, Jie, et al.
Publicado: (2019) -
The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)